|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 38/39 | |
| C07K 16/18 | |||
| C07K 16/28 | |||
| C12N 15/11 | |||
| A61P 39/00 | |||
| C07K 14/705 | |||
| C07K 14/78 | |||
| A61K 39/00 | |||
| A61N 5/10 | |||
| C12N 15/113 |
| (11) | Number of the document | 2340034 |
| (13) | Kind of document | T |
| (96) | European patent application number | 09791202.6 |
| Date of filing the European patent application | 2009-08-05 | |
| (97) | Date of publication of the European application | 2011-07-06 |
| (45) | Date of publication and mention of the grant of the patent | 2016-01-27 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/US2009/052902 |
| Date | 2009-08-05 |
| (87) | Number | WO 2010/017332 |
| Date | 2010-02-11 |
| (30) | Number | Date | Country code |
| 86991 P | 2008-08-07 | US |
| (72) |
ISENBERG, Jeffrey, S., US
ROBERTS, David, D., US
MAXHIMER, Justin, US
|
| (73) |
The United States Of America, As Represented By The Secretary, Department of Health and Human Services,
Office Of Technology Transfer 6011 Executive Blvd. Suite 325, Msc 7660, Bethesda, MD 20892-7660,
US
|
| (54) | RADIOPROTECTANTS TARGETING THROMBOSPONDIN-1 AND CD47 |
| RADIOPROTECTANTS TARGETING THROMBOSPONDIN-1 AND CD47 |